Myalept Alternatives Compared
Myalept | Egrifta | Tesamorelin |
|
---|
Myalept (metreleptin) | Egrifta (tesamorelin) | Tesamorelin |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Lipodystrophy. Myalept may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lipodystrophy. Egrifta may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lipodystrophy. tesamorelin may also be used for purposes not listed in this medication guide. |
Related suggestions Lipodystrophy
|
|||||||||||||||
More about Myalept (metreleptin) | More about Egrifta (tesamorelin) | More about Tesamorelin | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Egrifta has an average rating of 6.0 out of 10 from a total of 19 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 20% reported a negative effect. |
Tesamorelin has an average rating of 6.2 out of 10 from a total of 21 ratings on Drugs.com. 41% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: Myalept side effects in more detail. |
See also: Egrifta side effects in more detail. |
See also: tesamorelin side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Myalept prices |
View all Egrifta prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
N/A |
Egrifta | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
4.7 hours |
0.63 hours |
0.63 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 186 drugs are known to interact with Myalept:
|
A total of 48 drugs are known to interact with Egrifta:
|
A total of 48 drugs are known to interact with tesamorelin:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
||||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.